Cleerly® AI-Assisted Coronary CT Angiography (CCTA) in Portland & Lake Oswego

At HormoneSynergy®, we offer Cleerly® AI-assisted coronary CT angiography (CCTA) as part of a more advanced preventive cardiology approach. This noninvasive imaging analysis helps clarify coronary plaque burden and plaque characteristics, allowing for a more detailed understanding of cardiovascular risk and a more personalized prevention strategy.

Unlike a limited screening model focused only on standard cholesterol numbers or a basic calcium score, this approach is designed to give a broader view of coronary artery health and help guide decisions around lifestyle, metabolic risk reduction, and treatment planning.

If you are looking for a more complete, physician-led approach, you can schedule a preventive cardiology consultation here.

What Is Cleerly® AI-CCTA?

Cleerly® uses artificial intelligence to analyze coronary CT angiography images and provide a more detailed assessment of plaque burden and plaque features. Rather than identifying only calcified plaque, this analysis evaluates both calcified and non-calcified plaque, which can offer a more complete picture of coronary artery disease risk in appropriately selected patients.

Why Consider Cleerly® Testing?

For patients who want greater clarity around cardiovascular risk, Cleerly® testing can provide more detailed and actionable information than more basic screening alone. It may help identify plaque earlier, support a more goal-directed prevention strategy, and provide a visual, report-based framework for discussing risk over time.

This type of imaging may be particularly useful when there is uncertainty about true risk, concern about inherited cardiovascular burden, or a desire to refine prevention decisions with better anatomic data.

Who Is a Good Candidate?

Cleerly® AI-CCTA may be appropriate for individuals with a family history of early heart disease or stroke, elevated ApoB, LDL-C, triglycerides, or Lp(a), and for those with hypertension, insulin resistance, prediabetes, or metabolic syndrome.

It may also be helpful for perimenopausal or menopausal women, midlife men with changing cardiometabolic risk, and patients participating in weight-management or GLP-1 programs who want a more detailed understanding of their cardiovascular status.

Cleerly® vs. Coronary Artery Calcium (CAC) Scoring

A coronary artery calcium (CAC) score measures calcified plaque only. Cleerly® AI-CCTA provides a more detailed analysis by evaluating both calcified and non-calcified plaque, which can offer a more nuanced view of coronary artery disease burden when clinically indicated.

For some patients, a CAC score is an appropriate first step. For others, especially when a more detailed understanding of plaque is needed, Cleerly® analysis may provide more useful information for risk stratification and planning.

What to Expect

The process typically begins with a physician review of health history, cardiometabolic risk factors, and the reason for testing. The scan itself is performed through a partner imaging center, followed by Cleerly® image processing and report generation.

Once the report is complete, findings are reviewed in the context of your overall health picture, including visualization of plaque burden and discussion of the prevention plan that best fits your risk profile.

Your Personalized Prevention Plan

Testing is only useful when it leads to a thoughtful and individualized prevention strategy. At HormoneSynergy®, recommendations are based on your imaging findings, laboratory data, metabolic profile, and broader health goals.

This may include nutrition guidance, aerobic and resistance training planning, sleep and stress support, targeted evidence-informed supplements such as omega-3s, vitamin D3/K2, and magnesium, as well as medication recommendations when appropriate. Ongoing monitoring through repeat laboratory testing and selected imaging follow-up may also be part of the process.

Why Choose HormoneSynergy®

HormoneSynergy® offers a physician-led preventive cardiology model that integrates advanced imaging, laboratory evaluation, and lifestyle medicine into a more complete view of cardiovascular and metabolic health. This allows Cleerly® testing to be interpreted within a broader clinical framework rather than as a stand-alone report.

For many patients, this approach also aligns naturally with related work in medical weight loss, hormone optimization, and long-term longevity planning.

Related Longevity Medicine Resources

To explore the broader systems connected to cardiovascular and metabolic risk, you may also find these resources helpful: preventive cardiology and longevity medicine, fasting insulin and metabolic health, insulin resistance explained, and personalized longevity medicine.

Frequently Asked Questions

What is Cleerly® AI-assisted CCTA?

Cleerly® AI-assisted coronary CT angiography is an imaging analysis that evaluates coronary plaque using artificial intelligence, including both calcified and non-calcified plaque, to provide a more detailed picture of coronary artery disease risk.

How is Cleerly® different from a calcium score?

A calcium score measures calcified plaque only. Cleerly® AI-CCTA evaluates both calcified and non-calcified plaque and may provide a more detailed assessment of coronary artery disease when clinically appropriate.

Who may benefit from Cleerly® testing?

This testing may be useful for individuals with family history of early heart disease, elevated ApoB or Lp(a), metabolic risk factors, or uncertainty about their true cardiovascular risk.

Is Cleerly® testing invasive?

No. Cleerly® analysis is based on coronary CT angiography, which is a noninvasive imaging study performed at an imaging center.

How are results used at HormoneSynergy®?

Results are reviewed alongside your broader cardiometabolic and longevity profile to help guide nutrition, exercise, supplementation, medication planning, and follow-up strategy when appropriate.